An official website of the United States government
Use of COVID-19 Vaccines in the United States
Interim Clinical Considerations
Some 2023-2024 COVID-19 vaccines will expire in summer 2024. Expiration dates vary by manufacturer and vaccine. Always check the expiration date or beyond-use date/time to ensure it has not passed. Never use expired vaccine or diluent.
See the Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States for information on interchangeability of COVID-19 vaccines.
Summary of recent changes (last updated April 4, 2024):
- New guidance on COVID-19 vaccination and pemivibart (Pemgarda™), a monoclonal antibody authorized for COVID-19 pre-exposure prophylaxis in people who are moderately or severely immunocompromised and meet the FDA-authorized conditions for use.
Reference Materials
- COVID-19 Vaccine Product Information (Updated 3/19/2024)
- Interim 2023–2024 COVID-19 Immunization Schedule for Persons 6 Months of Age and Older (Updated 4/03/2024)
- FAQs for the Interim Clinical Considerations (Updated 4/5/2024)
- COVID-19 Vaccination Recommendations Infographic (Updated 3/5/2024)
- COVID-19 Vaccination Recommendations Infographic (Immunocompromised) (Updated 10/13/2023)
Get Email Updates
Receive email updates about this page.
Special Situations and Populations